Skip to main content

Antibodies could combat prion-based diseases

The discovery that antibodies seem to be effective against prions could open the door to immunisation against spongiform encephalopathies.

Written bySimon Frantz
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

LONDON A team from Imperial College School of Medicine are hopeful that they have discovered a way to prevent and destroy prion-based infections, such as scrapie, BSE and vCJD. A study, published in July 31 Proceedings of the National Academy of Sciences, found that treating cell cultures susceptible to mouse scrapie with an anti-prion antibody not only prevented infection of these cells but also cured chronically infected cultures (Proc Natl Acad Sci USA, 2001 198:9295-9299).

Enari et al. suggested that their findings support the idea that immunisation could provide a feasible therapy for prion-based diseases; although they admit there still is a long way to go before this could become a clinical reality. "These are tissue culture cells, so we still have to find whether the same thing happens in animals, let alone in people," Charles Weissmann, who led the research at the Medical Research Council's Prion Unit at St ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo